Cardiovascular disease has a significant genetic component, but it is not purely genetic. Large twin studies estimate the heritability of coronary artery disease at roughly 50% to 60%, meaning about half your risk comes from the genes you inherit and the other half from lifestyle and environmental factors. Some forms of heart disease trace back to a single gene mutation, while the more common types result from dozens or even hundreds of small genetic variations interacting with how you eat, move, and live.
How Much of Heart Disease Risk Is Inherited?
The 50% to 60% heritability figure comes from studies comparing identical twins (who share all their DNA) with fraternal twins (who share about half). When identical twins develop coronary artery disease at much higher matching rates than fraternal twins, researchers can estimate how much genetics contributes. The remaining 40% to 50% of risk comes from factors like diet, physical activity, smoking, blood pressure, and body weight, along with interactions between those factors and your genes.
This means having a family history of heart disease genuinely raises your risk, but it does not seal your fate. Your genes set a baseline level of vulnerability. What you do with that baseline matters enormously.
Family History as a Warning Sign
Doctors pay close attention to whether heart disease runs in your family, particularly if it showed up early. The standard threshold for “premature” heart disease is before age 55 in male relatives and before age 65 in female relatives. If a parent or sibling had a heart attack, stroke, or needed a stent or bypass before those ages, your own risk is meaningfully higher than someone without that history.
This family history effect holds even after accounting for shared habits like diet and smoking. It reflects the genetic variants passed from parent to child that influence cholesterol processing, blood vessel integrity, inflammation, and blood clotting.
Single-Gene Conditions That Cause Heart Disease
Some cardiovascular diseases are caused by a mutation in just one gene. These are less common but tend to be more severe and more predictable. The most well-known example is familial hypercholesterolemia (FH), a condition that causes dangerously high cholesterol from birth. The heterozygous form, where you inherit one copy of the faulty gene, affects roughly 1 in 313 people worldwide, totaling over 30 million individuals. The homozygous form, where both copies are affected, is far rarer and far more dangerous.
FH is caused by mutations in genes that control how your body clears LDL cholesterol from the blood. Without treatment, people with FH can develop heart disease decades earlier than expected. Many don’t know they have it until a cardiac event forces the discovery.
Other single-gene cardiovascular conditions include hypertrophic cardiomyopathy (where the heart muscle thickens abnormally), long-QT syndrome and Brugada syndrome (which cause dangerous heart rhythm problems), and conditions that weaken the aorta, making it prone to tearing. The American Heart Association maintains lists of specific genes associated with each of these conditions, and genetic testing panels can screen for them when family history or symptoms raise suspicion.
Congenital Heart Defects
Heart defects present at birth also have a genetic dimension, though it is complex. Specific genetic causes can be identified in about 40% of congenital heart disease cases. These break down into chromosomal abnormalities (about 13%), deletions or duplications of DNA segments (10% to 15%), and single-gene disorders (about 12%). The remaining 60% of congenital heart defects have no identified genetic cause, suggesting environmental exposures during pregnancy or random developmental errors also play a role.
The Polygenic Picture: Many Small Risks Adding Up
For the majority of people, heart disease risk is not driven by one dramatic mutation. It is shaped by hundreds or thousands of common genetic variants, each contributing a tiny amount of risk or protection. Researchers now combine these into a single number called a polygenic risk score.
A polygenic risk score works by tallying up all the small-effect genetic variants in your DNA, weighting each by how strongly it is linked to heart disease, and producing a score that reflects your overall genetic predisposition. People in the top percentiles of these scores can carry a risk comparable to having a single high-impact mutation like FH, even though no individual variant in their genome would raise an alarm on its own.
When added to traditional risk calculators that use age, blood pressure, cholesterol, and smoking status, polygenic risk scores modestly improve prediction accuracy. They are especially useful for reclassifying people who fall into borderline risk categories, helping clarify whether someone truly needs more aggressive prevention. These scores currently work best for people of European descent, since the underlying research has disproportionately studied those populations. Accuracy in other ethnic groups is improving but still lags behind.
Lipoprotein(a): A Highly Genetic Risk Factor
One of the strongest genetically driven risk factors for heart disease is a blood particle called lipoprotein(a), or Lp(a). Unlike regular LDL cholesterol, your Lp(a) level is 70% to 90% determined by your genes and stays remarkably stable throughout your life. Diet and exercise have little effect on it, and most standard cholesterol medications don’t lower it meaningfully.
Elevated Lp(a) affects roughly 1.5 billion people worldwide and is now recognized as an independent, causal risk factor for atherosclerosis (plaque buildup in arteries), stroke, and calcification of heart valves. It adds risk on top of every other factor, including LDL cholesterol and blood pressure. A single measurement taken in middle age provides long-term prognostic information, which is why more cardiologists are recommending that people get tested at least once.
How Lifestyle Modifies Genetic Risk
Having a high genetic risk for heart disease does not mean prevention is pointless. The opposite is true: people with the highest genetic risk stand to benefit the most from healthy habits. This works partly through epigenetics, the process by which lifestyle and environment change how your genes are expressed without altering the DNA sequence itself.
Regular physical activity, including both high-intensity interval training and combined strength-and-cardio routines, triggers epigenetic changes that improve how your body handles inflammation, blood sugar, and energy production. Dietary patterns like the Mediterranean and DASH diets have been shown to promote favorable shifts in gene expression and slow epigenetic aging. Even stress management through mindfulness and meditation can alter the expression of genes involved in inflammation and blood pressure regulation.
The flip side is equally powerful. Smoking and heavy alcohol use drive harmful epigenetic changes that accelerate disease progression. Chronic stress alters genes involved in the body’s stress response pathways. These changes can accumulate over time, compounding whatever genetic predisposition you started with. The key insight is that your genes and your environment are in constant conversation. You cannot change the DNA you were born with, but you can change the signals your body sends to those genes every day.
Genetic Testing for Heart Disease
Genetic testing for cardiovascular disease falls into two broad categories. The first is targeted testing for single-gene conditions, typically recommended when you have a strong family history of early heart disease, unexplained heart muscle problems, sudden cardiac death in a relative, or very high cholesterol that doesn’t respond to standard treatment. These tests look at specific panels of genes. For example, testing for familial hypercholesterolemia focuses on three main genes that control LDL cholesterol clearance. Testing for cardiomyopathies examines a broader set of genes affecting heart muscle structure.
The second category is polygenic risk scoring, which is newer and less established in clinical practice. Some cardiology centers and direct-to-consumer companies now offer these scores, but their clinical utility is still being refined. They are most helpful as one input among many, not as a standalone prediction.
If testing reveals a genetic condition, the value extends beyond you. First-degree relatives, including your parents, siblings, and children, can be tested through what is called cascade screening. Catching a condition like FH in a sibling or child before symptoms appear allows treatment to start years or decades earlier, which dramatically reduces the chance of a heart attack.
Gene Therapies on the Horizon
For single-gene conditions, gene-based treatments are advancing rapidly. An RNA-silencing drug called inclisiran is already FDA-approved for people with familial hypercholesterolemia whose cholesterol remains too high on standard therapy. It works by blocking the production of a protein that prevents your liver from clearing LDL cholesterol, and it requires only two injections per year.
More ambitious approaches using gene-editing technology are in early clinical trials. These aim to make permanent, one-time corrections to the genes responsible for high cholesterol, potentially offering a cure rather than ongoing treatment. Other trials are exploring gene therapies for conditions affecting the heart muscle and aorta. While most of these remain years from widespread availability, they represent a future where the genetic component of heart disease may become directly treatable at its source.